The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats-Reference-Cited by-同舟云学术

The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats

Published:2018-07-03 Issue:7 Volume:143 Page:1817-1828
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Liu Yewei¹²³⁴^ORCID,De Keyzer Frederik¹,Wang Yixin¹,Wang Fengna¹,Feng Yuanbo¹,Chen Feng¹,Yu Jie¹,Liu Jianjun³,Song Shaoli³,Swinnen Johan¹,Bormans Guy¹,Oyen Raymond¹,Huang Gang²³⁴,Ni Yicheng¹

Affiliation:

1. Biomedical Group, Campus Gasthuisberg, KU LeuvenLeuven Belgium

2. Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine and Health SciencesShanghai China

3. Institute of Clinical Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of MedicineShanghai China

4. Institute of Health Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) & Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS)Shanghai China

Funder

KU Leuven

European Commission

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31567

Reference40 articles.

1. Drug Insight: vascular disrupting agents and angiogenesis—novel approaches for drug delivery